Literature DB >> 23988415

Tracer injection sites and combinations for sentinel lymph node detection in patients with endometrial cancer.

Hitoshi Niikura1, Michiko Kaiho-Sakuma, Hideki Tokunaga, Masafumi Toyoshima, Hiroki Utsunomiya, Satoru Nagase, Tadao Takano, Mika Watanabe, Kiyoshi Ito, Nobuo Yaegashi.   

Abstract

OBJECTIVE: The aim of the present study was to clarify the most effective combination of injected tracer types and injection sites in order to detect sentinel lymph nodes (SLNs) in early endometrial cancer. PATIENTS AND METHODS: The study included 100 consecutive patients with endometrial cancer treated at Tohoku University Hospital between June 2001 and December 2012. The procedure for SLN identification entailed either radioisotope (RI) injection into the endometrium during hysteroscopy (55 cases) or direct RI injection into the uterine cervix (45 cases). A combination of blue dye injected into the uterine cervix or uterine body intraoperatively in addition to preoperative RI injection occurred in 69 of 100 cases. All detected SLNs were recorded according to the individual tracer and the resultant staging from this method was compared to the final pathology of lymph node metastases including para-aortic nodes.
RESULTS: SLN detection rate was highest (96%) by cervical RI injection; however, no SLNs were detected in para-aortic area. Para-aortic SLNs were detected only by hysteroscopic RI injection (56%). All cases with pelvic lymph node metastases were detected by pelvic SLN biopsy. Isolated positive para-aortic lymph nodes were detected in 3 patients. Bilateral SLN detection rate was high (96%; 26 of 27 cases) by cervical RI injection combined with dye.
CONCLUSION: RI injection into the uterine cervix is highly sensitive in detection of SLN metastasis in early stage endometrial cancer. It is a useful and safe modality when combined with blue dye injection into the uterine body.
© 2013.

Entities:  

Keywords:  (99m)Tc-phytate; Endometrial cancer; Frozen section; Micrometastasis; Sentinel lymph node (SLN)

Mesh:

Substances:

Year:  2013        PMID: 23988415     DOI: 10.1016/j.ygyno.2013.08.018

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  Sentinel lymph node mapping using SPECT/CT and gamma probe in endometrial cancer: an analysis of parameters affecting detection rate.

Authors:  Samine Sahbai; Florin-Andrei Taran; Annette Staebler; Diethelm Wallwiener; Christian la Fougère; Sara Brucker; Helmut Dittmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-04-03       Impact factor: 9.236

2.  Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.

Authors:  Shinichi Togami; Hiroaki Kobayashi; Hitoshi Niikura; Muneaki Shimada; Nobuyuki Susumu; Tomohito Tanaka; Yoshito Terai; Tomoyuki Nagai; Tsukasa Baba; Hideaki Yahata; Wataru Yamagami; Ken Yamaguchi; Tsuyoshi Yamashita; Nobuo Yaegashi; Hidetaka Katabuchi; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2021-03-25       Impact factor: 3.402

Review 3.  Contributions of the Japanese Gynecologic Oncology Group (JGOG) in Improving the Quality of Life in Women With Gynecological Malignancies.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Muneaki Shimada; Shinya Sato; Etsuko Miyagi; Akiko Tozawa-Ono; Nao Suzuki; Masaki Fujimura; Yoichi Aoki; Satoru Sagae; Toru Sugiyama
Journal:  Curr Oncol Rep       Date:  2017-04       Impact factor: 5.075

4.  Validation of an Endometrial Tumor Diameter Model for Risk Assessment in the Absence of Lymph Node Mapping.

Authors:  McKayla J Riggs; Callie M Cox Bauer; Caela R Miller; James K Aden; Scott A Kamelle
Journal:  J Patient Cent Res Rev       Date:  2020-10-23

Review 5.  Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.

Authors:  Robert W Holloway; Nadeem R Abu-Rustum; Floor J Backes; John F Boggess; Walter H Gotlieb; W Jeffrey Lowery; Emma C Rossi; Edward J Tanner; Rebecca J Wolsky
Journal:  Gynecol Oncol       Date:  2017-05-28       Impact factor: 5.482

6.  Identification of Predictive Biomarkers for Lymph Node Involvement in Obese Women With Endometrial Cancer.

Authors:  Vanessa M López-Ozuna; Liron Kogan; Mahmood Y Hachim; Emad Matanes; Ibrahim Y Hachim; Cristina Mitric; Lauren Liu Chen Kiow; Susie Lau; Shannon Salvador; Amber Yasmeen; Walter H Gotlieb
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

Review 7.  Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.

Authors:  Lirong Zhai; Xiwen Zhang; Manhua Cui; Jianliu Wang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

8.  Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer.

Authors:  Hans Nagar; Nina Wietek; Richard J Goodall; Will Hughes; Mia Schmidt-Hansen; Jo Morrison
Journal:  Cochrane Database Syst Rev       Date:  2021-06-09

9.  A prospective pilot study of detection of sentinel lymph nodes in gynaecological cancers using a novel near infrared fluorescence imaging system.

Authors:  Alexandros Laios; Davide Volpi; Iain D C Tullis; Martha Woodward; Stephen Kennedy; Pubudu N J Pathiraja; Krishnayan Haldar; Borivoj Vojnovic; Ahmed A Ahmed
Journal:  BMC Res Notes       Date:  2015-10-26

10.  A critical assessment on the role of sentinel node mapping in endometrial cancer.

Authors:  Giorgio Bogani; Antonino Ditto; Fabio Martinelli; Mauro Signorelli; Stefania Perotto; Domenica Lorusso; Francesco Raspagliesi
Journal:  J Gynecol Oncol       Date:  2015-10-08       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.